Thermo Fisher Partner with University of Birmingham’s New Phenome Centre
Thermo Fisher Scientific has extended a technology collaboration with the University of Birmingham in the UK. Thermo Fisher will supply a range of mass spectrometry instruments to be used at the University’s new Phenome Centre.
Thermo Fisher Scientific (San Jose, California, USA) has extended a technology collaboration with the University of Birmingham in the UK. Thermo Fisher will supply a range of mass spectrometry instruments to be used at the University’s new Phenome Centre.
The £8 million facility provides University of Birmingham scientists with the tools needed to conduct large-scale metabolic phenotyping research, advancing the understanding of biochemical mechanisms, targets, and biomarkers associated with ageing and disease.
“We are pleased to continue our long-standing collaboration with Thermo Fisher in these important areas of metabolome research,” said Professor Mark Viant, Director of Phenome Centre Birmingham.
“Combined with our strong impact in technology and method development, we look forward to the benefits we will translate to the human population through stratified medicine approaches,” continued Viant.
Stratified medicine, a method of predicting which treatments cancers are likely to respond to by studying the cells and genetic make up of large groups of cancer patients, is part of the larger strategy employed at the facility.
Iain Mylchreest, vice president of R&D for chromatography and mass spectrometry at Thermo Fisher, congratulated the university on the opening of the Phenome Centre, adding, “These scientific relationships are mutually beneficial in helping us to advance our analytical tools and technologies that, in turn, enable our customers to make the world healthier, cleaner, and safer.”
This recent collaboration is just one of many between the University of Birmingham and Thermo Fisher across 10 years. Most recently, the organizations have collaborated to accelerate research in high-resolution accurate mass (HRAM) and triple quadrupole liquid chromatography-mass spectrometry (LC–MS) for life sciences applications.- L.B.
For more information about Thermo Scientific, please visit www.thermofisher.com
For further information about the Phenome Centre Birmingham, please visit www.birmingham.ac.uk/research/activity/phenome-centre
AI and GenAI Applications to Help Optimize Purification and Yield of Antibodies From Plasma
October 31st 2024Deriving antibodies from plasma products involves several steps, typically starting from the collection of plasma and ending with the purification of the desired antibodies. These are: plasma collection; plasma pooling; fractionation; antibody purification; concentration and formulation; quality control; and packaging and storage. This process results in a purified antibody product that can be used for therapeutic purposes, diagnostic tests, or research. Each step is critical to ensure the safety, efficacy, and quality of the final product. Applications of AI/GenAI in many of these steps can significantly help in the optimization of purification and yield of the desired antibodies. Some specific use-cases are: selecting and optimizing plasma units for optimized plasma pooling; GenAI solution for enterprise search on internal knowledge portal; analysing and optimizing production batch profitability, inventory, yields; monitoring production batch key performance indicators for outlier identification; monitoring production equipment to predict maintenance events; and reducing quality control laboratory testing turnaround time.
2024 EAS Awardees Showcase Innovative Research in Analytical Science
November 20th 2024Scientists from the Massachusetts Institute of Technology, the University of Washington, and other leading institutions took the stage at the Eastern Analytical Symposium to accept awards and share insights into their research.
